Skip to main content
Microbiology Spectrum logoLink to Microbiology Spectrum
. 2022 Nov 23;10(6):e03285-22. doi: 10.1128/spectrum.03285-22

Associations of Rap1 with Cell Wall Integrity, Biofilm Formation, and Virulence in Candida albicans

Wen-Han Wang a,#, Ting-Xiu Lai a,#, Yi-Chia Wu a, Zzu-Ting Chen b, Kuo-Yun Tseng a,c, Chung-Yu Lan a,b,d,
Editor: Rebecca S Shapiroe
PMCID: PMC9769648  PMID: 36416583

ABSTRACT

Rap1 (repressor activator protein 1) is a multifunctional protein, playing important roles in telomeric and nontelomeric functions in many eukaryotes. Candida albicans Rap1 has been previously shown to be involved in telomeric regulation, but its other functions are still mostly unknown. In this study, we found that the deletion of the RAP1 gene altered cell wall properties, composition, and gene expression. In addition, deletion of RAP1 affected C. albicans biofilm formation and modulated phagocytosis and cytokine release by host immune cells. Finally, the RAP1 gene deletion mutant showed attenuation of C. albicans virulence in a Galleria mellonella infection model. Therefore, these findings provide new insights into Rap1 functions that are particularly relevant to pathogenesis and virulence of C. albicans.

IMPORTANCE C. albicans is an important fungal pathogen of humans. The cell wall is the outermost layer of C. albicans and is important for commensalism and infection by this pathogen. Moreover, the cell wall is also an important target for antifungals. Studies of how C. albicans maintains its cell wall integrity are critical for a better understanding of fungal pathogenesis and virulence. This work focuses on exploring unknown functions of C. albicans Rap1 and reveals its contribution to cell wall integrity, biofilm formation, and virulence. Notably, these findings will also improve our general understanding of complex machinery to control pathogenesis and virulence of fungal pathogens.

KEYWORDS: Candida albicans, Rap1, cell wall integrity, biofilm, pathogenesis, virulence, biofilms

INTRODUCTION

Candida albicans is a commensal yeast inhabiting multiple body sites of healthy individuals, normally being innocuous (1). However, changes in the internal environment of the host, as exemplified by that in immunocompromised individuals, can promote C. albicans to become pathogenic and cause various infections including life-threatening disseminated candidiasis (2, 3). Therefore, the ability of C. albicans to adapt to changing environmental conditions is critical for its survival and pathogenicity.

The cell wall is the outermost structure of C. albicans, playing a vital role in maintenance of cell integrity, interaction with the host environment, and fungal pathogenesis (4, 5). Moreover, the cell wall is also one of the main targets of antifungal drugs (6, 7). The C. albicans cell wall is composed mainly of proteins and polysaccharides, forming two layers visualized by electron microscopy (8). The inner layer includes β-1,3-glucan, β-1,6-glucan, and chitin to form the core skeletal structure of the wall (8, 9). Moreover, the outer layer of the cell wall is enriched with heavily glycosylated mannoproteins cross-linked to β-1,3-glucan (10) and generally masks the inner β-glucan layer to reduce recognition of C. albicans by the host immune system (11, 12).

Although the C. albicans cell wall is tough, it can be flexible to change the relative amounts of its composition in response to the environment (1315). This underlying composition remodeling is thus crucial for the maintenance of cell wall integrity (CWI) and is regulated by various signaling pathways, including the Mkc1, Hog1, and Cek1 mitogen-activated protein (MAP) kinase cascades (15, 16). Moreover, a variety of transcription factors also contribute to the regulation of C. albicans CWI in response to external stresses. For example, Cas5, Czf1, and Rlm1 are on the list of CWI regulators (1719). Together, maintaining CWI requires complex interplays among multiple signaling pathways and transcription regulators.

Repressor activator protein 1 (Rap1) is a conserved DNA-binding protein identified in yeasts, protozoa, and mammalian cells (20). In the yeast Saccharomyces cerevisiae, Rap1 (ScRap1) plays an important role in telomere regulation by directly binding to double-stranded telomeric DNA. The molecular events regulated by ScRap1 are exemplified by subtelomeric gene silencing (21), telomere length control (22), and telomere end protection (2325). Nevertheless, ScRap1 is also involved in other functions not relevant to telomere regulation, including transcriptional regulation, metabolic control, and oxidative stress response (26, 27). In C. albicans, a homolog of ScRap1 has been identified and characterized. Similarly, C. albicans Rap1 participates in the control of telomere length and structure (2830). However, nontelomeric functions of C. albicans Rap1 are still largely unknown.

In this study, we have begun to reveal other functions of C. albicans Rap1, particularly those related to C. albicans pathogenesis. We demonstrated that deletion of C. albicans RAP1 alters cell wall properties, composition, and expression of genes related to cell wall biosynthesis and remodeling. Moreover, the deletion of RAP1 promoted activation of Mkc1 and Cek1 kinases and impacted C. albicans biofilm formation. Finally, the RAP1 gene deletion (rap1Δ/Δ) mutant also affected C. albicans-macrophage interaction and exhibited attenuated virulence in a Galleria mellonella infection model.

RESULTS

Deletion of RAP1 impacts C. albicans cell wall properties.

To explore nontelomeric functions of C. albicans Rap1, we generated the rap1Δ/Δ mutant and RAP1-reintegrated strains. The successful strain construction was verified by PCR analysis of genomic DNA (see Fig. S1 in the supplemental material). Moreover, the rap1Δ/Δ mutant was viable, indicating C. albicans RAP1 is not essential, which is consistent with previous findings (2830). Interestingly, we further found that the rap1Δ/Δ mutant, but not the wild type and RAP1-reintegrated controls, aggregated and formed flocs during cell growth in microplates (Fig. 1A). The formation of flocs was also assayed by sedimentation rate, showing that the rap1Δ/Δ mutant sediments faster than the controls (Fig. 1B).

FIG 1.

FIG 1

The RAP1 deletion causes alterations in cell wall-related properties in C. albicans. (A) Cell aggregation. Overnight cultures were transferred to each well of 24-well microplates and photographed immediately (top panel). Then, cells were shaken slowly (100 rpm) at 25°C for 30 min and photographed (bottom panel). A representative image from three independent experiments with identical results is shown. 1, wild type; 2 and 3, the rap1Δ/Δ mutants; 4 and 5, the RAP1-reintegrated strains. (B) Cell sedimentation. Overnight cultures were sedimented by standing at room temperature and photographed at different periods of time as indicated. (C) Cell susceptibility to cell wall-perturbing agents. Overnight cultures were spotted onto SC with or without drugs as indicated. Cells were incubated at 30°C for 3 days. A representative image from three independent experiments with identical results is shown. WT, wild type. (D) CSH assay. Cells were grown overnight, and CSH was determined. The results are displayed as the mean ± standard deviation from three independent experiments. *, P < 0.05; #, P = 0.076.

Since flocculation and sedimentation are known to be cell wall associated (31, 32), we thus hypothesized that deletion of RAP1 may lead to changes in the properties of the C. albicans cell wall. To test this hypothesis, cell susceptibility to cell wall-perturbing drugs was first examined. As shown in Fig. 1C, the rap1Δ/Δ mutant differed from the controls in its susceptibility to cell wall-perturbing drugs. The rap1Δ/Δ mutant was more sensitive to calcofluor white and Congo red but more resistant to tunicamycin. Moreover, because cell surface hydrophobicity (CSH) contributes to C. albicans aggregation and adhesion (33), the CSH levels were also compared between the rap1Δ/Δ mutant and the wild-type and RAP1-reintegrated strains. Indeed, the CSH of the rap1Δ/Δ mutant was increased compared to the controls (Fig. 1D).

Deletion of RAP1 causes alterations of cell wall carbohydrate content.

The cell wall consists of polysaccharides and proteins, and the former account for a large portion of the dry weight of the cell wall (5). Moreover, CSH is closely associated with cell wall compositions (34). Therefore, carbohydrate content in the cell wall was also measured. Total carbohydrate content in the cell wall was increased by approximately 40% in the rap1Δ/Δ mutant compared to the controls (Fig. 2A). Glucan, mannan, and chitin are the three major polysaccharides of the C. albicans cell wall. To further examine the effect of RAP1 deletion, the content of each polysaccharide was quantified using high-performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD) analysis. The results show that contents of all three polysaccharides were increased in the rap1Δ/Δ mutant (Fig. 2B).

FIG 2.

FIG 2

The RAP1 deletion leads to changes in cell wall carbohydrate contents and the expression of cell wall-related genes. (A) Measurement of total carbohydrate contents of the cell wall. The results are displayed as the mean ± standard deviation from three independent experiments. **, P < 0.01. (B) Quantification of the cell wall chitin, glucan, and mannan content by HPAEC-PAD. The results are displayed as the mean ± standard deviation from three independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001. WT, wild type. (C) The expression of cell wall biosynthesis and remodeling genes. RT real-time qPCR was performed, and ACT1 transcripts were used as an internal control. The results are presented as the mean ± standard deviation from at least three independent experiments. **, P < 0.01; ***, P < 0.001.

Because deletion of RAP1 affects cell wall properties and composition, we suspected that Rap1 may act as a transcription regulator to control the expression of cell wall-related genes. To test this possibility, reverse transcription (RT) real-time quantitative PCR (qPCR) analysis was performed to measure expression of genes encoding enzymes for cell wall biosynthesis and remodeling (35, 36). Although there was no significant difference in CHS1, CHS3, FKS1, and FKS2 gene expression (Fig. S2 in the supplemental material), modulation of many other genes was detected in the rap1Δ/Δ mutant compared to the wild-type and RAP1-reintegrated strains (Fig. 2C). Among these differentially expressed genes, CHS2 and CHS8 are involved in chitin synthesis. Moreover, increased expression was shown in the XOG1, PHR1, and BGL2 genes (~5-, 6.5-, and 1.7-fold), which encode exo-1,3-β-glucanase, glycosidase, and 1,3-β-glucosyltransferase, respectively (3739). Finally, the OCH1 gene product is a mannosyltransferase, participating in mannosylation of cell wall proteins (2, 10).

The Mkc1 and Cek1 MAP kinases are activated in the rap1Δ/Δ mutant.

In response to environmental changes and stresses, distinct signaling pathways are activated in C. albicans. Importantly, the effect of many environmental factors is transduced through three major MAP kinase pathways in C. albicans, including the Mkc1, Cek1, and Hog1 cascades (4042). The Mkc1 pathway is associated with the maintenance of CWI mainly due to its functions in cell wall biogenesis (4345). Moreover, the Cek1 and Hog1 pathways are also known to contribute to cell wall construction (4648).

Here, to further correlate Rap1 with CWI maintenance, we also determined activation of MAP kinases in the rap1Δ/Δ mutant using Western blot analysis. As shown in Fig. 3, the phosphorylation levels of Mkc1 and Cek1 were increased in the rap1Δ/Δ mutant compared to the wild-type and RAP1-reintegrated strains. However, there was no significant difference in the levels of phospho-Hog1 among all the strains examined (Fig. S3). Together, these results and the findings that RAP1 deletion affects susceptibility to cell wall-perturbing drugs, cell wall properties and composition, and cell wall-related gene expression (Fig. 1 and 2) suggest the potential relationship between Rap1 and CWI in C. albicans.

FIG 3.

FIG 3

Mkc1 and Cek1 are activated in the rap1Δ/Δ mutant. Mkc1 and Cek1 activation were detected by Western blot analysis. Equal amounts of proteins (25 μg) from each strain were loaded. Cells treated with calcofluor white (CFW) were used as a positive control. The phosphorylated Mkc1 (Mkc1-P) and Cek1 (Cek1-P) were analyzed using ImageJ software. Act1 was used as a loading control and was used to normalize Mkc1-P and Cek1-P levels indicated by the fold change values. The data are representative of three independent experiments with identical results.

RAP1 deletion also affects biofilm formation.

The cell wall is closely connected with biofilm formation on abiotic or biotic surfaces, which is important for pathogenicity of C. albicans (2, 14, 49). In addition, using a computational approach, Rap1 was identified as a transcription factor potentially related to C. albicans biofilm formation (50). Because of the influence of RAP1 deletion on CWI (Fig. 1 to 3), we hypothesized that C. albicans biofilm formation might also be affected in the rap1Δ/Δ mutant. To assay the formation of biofilm, the XTT [2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide] reduction method was used. Indeed, the rap1Δ/Δ mutant formed a robust biofilm compared to those of the wild-type and RAP1-reintegrated strains (Fig. 4A and B). Moreover, the structure of biofilm was also examined by scanning electron microscopy (SEM). As demonstrated in Fig. 4C, the wild-type and RAP1-reintegrated strains formed biofilms with a single layer of cells. However, the rap1Δ/Δ mutant formed a biofilm with a complicated three-dimensional structure (Fig. 4C). Concisely, RAP1 deletion enhances C. albicans biofilm formation.

FIG 4.

FIG 4

Rap1 is involved in biofilm formation. (A) Biofilms were formed in each well of a 24-well polystyrene microplate in SC medium and incubated at 37°C with 5% CO2 for 24 h. (B) Measurement of biofilm formation using the XTT reduction method. The results are presented as the mean ± standard deviation from three independent assays. **, P < 0.01. (C) Biofilm structure was examined using SEM. The cells were grown on polystyrene coverslips for 24 h to form biofilms. Pictures were taken at an ×1,000 magnification. Bars, 50 μm.

Cell wall changes by RAP1 deletion have impacts on C. albicans-macrophage interaction.

Because the cell wall plays a critical role in the interaction of C. albicans with the host immune system, we reasoned that cell wall changes caused by RAP1 deletion would affect immune recognition and response (51, 52). The rates of C. albicans engulfment and cytokine secretion by J774A.1 macrophages were thus examined. As indicated in Fig. 5A, a much lower percentage of cell uptake by macrophages was found in the rap1Δ/Δ mutant than in the wild-type and RAP1-reintegrated strains. Besides, macrophage-mediated responses were also determined by detecting cytokine secretion using an enzyme-linked immunosorbent assay (ELISA). When macrophages were infected with the rap1Δ/Δ mutant, the levels of tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6) secretion were lower than those in macrophages infected with the wild-type and RAP1-reintegrated strains (Fig. 5B and C). These results suggest that RAP1 deletion-mediated cell wall changes give rise to diminished recognition and engulfment by macrophages and a reduced proinflammatory cytokine response.

FIG 5.

FIG 5

The RAP1 deletion has impacts on C. albicans-macrophage interaction. (A) Macrophage phagocytosis assay. C. albicans cells were coincubated with J774A.1 macrophages (at an MOI of 3) for 30 min, and the phagocytosis rates were determined. The results are expressed as the mean ± standard deviation from three independent assays. **, P < 0.01. (B and C) Measurement of TNF-α (B) and IL-6 (C) production. C. albicans cells were coincubated with J774A.1 cells (at an MOI of 3), and production of cytokines was measured using ELISA. Uninfected J774A.1 cells were used as a negative control. The results are expressed as the mean ± standard deviation from three independent assays. **, P < 0.01; ***, P < 0.001.

RAP1 deletion attenuates C. albicans virulence.

To investigate the influence of Rap1 on C. albicans virulence, a G. mellonella infection model was used. G. mellonella larvae infected with the rap1Δ/Δ mutant showed an overall higher survival rate than that of larvae infected with the wild-type and RAP1-reintegrated strains (Fig. 6A). Moreover, the fungal load from larvae infected with the rap1Δ/Δ mutant was significantly decreased compared to the load from those infected with the control strains (Fig. 6B). These results indicate that RAP1 deletion attenuates C. albicans virulence.

FIG 6.

FIG 6

Rap1 contributes to C. albicans virulence. (A) Assessment of survival rate of G. mellonella. A total of 5 × 105 C. albicans cells was injected into larvae of G. mellonella (n = 15 per C. albicans strain). The survival rates were monitored daily for 10 days. Larvae inoculated with PBS were used as a vehicle control. ***, P < 0.001. (B) Assessment of fungal load. A total of 6 × 105 C. albicans cells was injected into larvae of G. mellonella (n = 10 per C. albicans strain). Hemolymph of larvae was collected 1 day postinfection and plated on YPD agar plates, and numbers of CFU were counted. Larvae inoculated with PBS were used as a control. Each symbol represents an individual larva. Horizontal lines show the mean ± standard deviation. ***, P < 0.001.

DISCUSSION

Rap1 is a conserved multifunctional protein involved in various cellular processes, of which telomere regulation is one of the most studied events (26, 27). For example, ScRap1 controls subtelomeric gene silencing (21) and telomere length (22) and protects chromosomes from DNA damage caused by unwanted DNA repair mechanisms and abnormal chromosome fusions (2325, 53, 54). Although ScRap1 and its orthologs have similar functions in telomere regulation, interestingly, they can act differently. ScRap1 can directly recognize telomeric DNA, whereas human Rap1 (hRap1) cannot bind DNA directly and is recruited to telomeres through its protein partner hTRF2 (53). Moreover, ScRap1 and hRap1 play a similar role in other nontelomeric functions, including transcriptional control, metabolism, and oxidative stress response (26), while hRap1 contributes to inflammation related to human diseases (26, 55).

Apart from telomere regulation, both ScRap1 and hRap1 also act as transcription regulators. For example, ScRap1 activates genes encoding glycolytic enzymes and ribosomal proteins (56, 57). To study ScRap1 in transcription regulation, extensive studies have established structure-function relationships of the protein. ScRap1 can be roughly divided into three regions: the N-terminal and C-terminal domains and a central DNA-binding domain (DBD). The N-terminal domain is suggested to elicit DNA bending and contains a BRCT (BRCA1 C terminus) domain that interacts with ScGcr1 to regulate glycolytic genes (58, 59). The DBD of ScRap1 has two Myb motifs and can directly interact with the TATA-binding protein (54, 60). Finally, the C-terminal domain, working with other proteins such as ScRif1, ScRif2, ScSir3, and ScSir4, is required for regional silencing at several loci on chromatins (6166).

In C. albicans, a homolog of ScRap1 was identified and characterized (28). Like ScRap1, C. albicans Rap1 was found to participate in controlling telomere length and structure (30). Intriguingly, there are several differences between ScRap1 and C. albicans Rap1. First, ScRap1 is an essential protein, whereas the C. albicans Rap1 is nonpivotal for cell viability (28). Second, C. albicans Rap1 lacks the C-terminal domain of ScRap1 (2830). Finally, C. albicans Rap1 represses the formation of pseudohyphae under conditions favoring growth as the yeast form (28). The role of ScRap1 in pseudohyphal growth has not been reported in S. cerevisiae. Therefore, it would be interesting to further reveal similarities and differences between functions of ScRap1 and C. albicans Rap1.

This work aimed to explore previously unknown functions of C. albicans Rap1. Since RAP1 is not essential in C. albicans, we generated the rap1Δ/Δ mutant to examine C. albicans RAP1 gene function. Our results indicate that C. albicans Rap1 is closely associated with CWI. The rap1Δ/Δ mutant aggregated, formed flocs, and sedimented faster than the control strains (Fig. 1A and B). In addition, the deletion of RAP1 caused alterations in cell surface hydrophobicity, cell susceptibility to cell wall-disrupting agents, and the chemical composition of the C. albicans cell wall (Fig. 1C and D and Fig. 2A and B). Interestingly, the N-terminal deletion mutant of ScRap1 was hypersensitive to cell wall-disrupting agents and changed the cell wall composition (67). These results suggest that the N-terminal domain of Rap1 may be also important in regulating CWI in C. albicans. However, further investigation is required. Finally, several cell wall biosynthesis and remodeling genes were modulated, and the Mkc1 and Cek1 MAP kinases were activated in the C. albicans rap1Δ/Δ mutant (Fig. 2C and Fig. 3). Together, our observations in the rap1Δ/Δ mutant provide evidence for the role of C. albicans Rap1 in regulating CWI.

Cell wall components, e.g., Als1, and CSH have been linked to C. albicans adhesion and biofilm formation (68, 69). According to our findings in Fig. 1D and Fig. 2A and B, the role of Rap1 in biofilm formation was thus determined. Biofilm formation in C. albicans involves complex processes including cell adhesion, yeast and hypha morphogenesis, and extracellular matrix (ECM) accumulation and dispersal (70, 71). Hyphae act as a supporting scaffold for yeast and other hyphal cells and contribute significantly to the overall architectural stability of the biofilm (71). Although deletion of RAP1 affected C. albicans biofilm formation (Fig. 4A to C), intriguingly, we found that the rap1Δ/Δ mutant still retains the ability to form hyphae, similar to the control strains (see Fig. S4 in the supplemental material). Therefore, to examine whether deletion of RAP1 has an impact on cell adhesion, ECM synthesis, and biofilm dispersal is of interest for future research.

Of note, components of the C. albicans cell wall represent the major pathogen-associated molecular patterns (PAMPs) that can be recognized by diverse pattern recognition receptors (PRRs) to trigger host immune responses (51, 72). Moreover, the cell wall is also important during C. albicans commensalism and infections (4, 11). Since cell wall properties and composition were changed in the rap1Δ/Δ mutant, we reasoned that RAP1 deletion may also affect the pathogenesis and virulence of C. albicans. Thus, phagocytosis and cytokine release from murine macrophages against C. albicans were thus examined. Our results indicate the rap1Δ/Δ mutant is more resistant to being phagocytosed than the wild-type and RAP1-reintegrated strains (Fig. 5A). Moreover, lower levels of TNF-α and IL-6 were also detected from macrophages infected with the rap1Δ/Δ mutant than from macrophages infected with the control strains (Fig. 5B and C). Finally, G. mellonella larvae were used to assess the effects of RAP1 deletion on C. albicans virulence. Indeed, a higher survival rate and a lower fungal burden were revealed from larvae infected with the rap1Δ/Δ mutant (Fig. 6A and B). In aggregate, our findings clearly show that Rap1 is associated with CWI, biofilm, and virulence in C. albicans.

In this work, we expanded the new roles of Rap1, particularly in the pathogenesis and virulence of C. albicans. However, many questions still need to be addressed. For example, it is still not clear whether C. albicans Rap1 directly or indirectly regulates target gene expression. In S. cerevisiae, the C-terminal domain of ScRap1 mediates the association of ScRap1 with other regulators to control transcription silencing of subtelomeric regions (7375). Because C. albicans Rap1 lacks the C-terminal domain of ScRap1, it will be interesting to further examine the domain structure-function relationship of C. albicans Rap1. Moreover, ScRap1 has been found to target ~5% of yeast genes and contribute to activation of ~37% of RNA polymerase II-mediated transcription (76). Therefore, the consensus of C. albicans Rap1-regulated promoters is also required to be determined. Moreover, other signaling components (e.g., the calcium-calcineurin pathway) and transcription factors (e.g., Cas5, Czf1, Rlm1, and Bcr1) can also regulate CWI and biofilm formation in C. albicans (1719, 77). Moreover, many other transcription factors have a role in biofilm formation (70). Further investigation will help us to understand the comprehensive cell wall regulating network.

MATERIALS AND METHODS

C. albicans strains, media, and growth conditions.

The C. albicans strains used in this work are listed in Table S1 (in the supplemental material). Cells were routinely maintained at −80°C and plated on YPD agar (1% yeast extract, 2% peptone, 2% glucose, and 1.5% agar) before each experiment. A single colony was inoculated into YPD broth and grown at 30°C overnight (~16 h) with shaking (180 rpm). The overnight culture was subcultured in synthetic complete (SC) medium (0.67% yeast nitrogen base [YNB] with ammonium sulfate, 0.079% complete supplement mixture [MP Biomedicals, Santa Ana, CA, USA], and 2% glucose) and grown at 30°C with shaking to the exponential phase. For the induction of the MAL2 promoter, YPM (1% yeast extract, 2% peptone, and 2% maltose) was used (78). All reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA) unless indicated otherwise.

Strain construction.

The rap1Δ/Δ mutant and the RAP1-reintegrated strains were generated using the SAT1-flipper method (78). The primers used are listed in Table S2 (in the supplemental material). The 5′ and 3′ flanking regions of RAP1 were amplified from the SC5314 genome using the primer pair Rap1-UR-F-ApaI and Rap1-UR-R-XhoI and the primer pair Rap1-DR-F-SacII and Rap1-DR-R-SacI, respectively. The resulting 5′ and 3′ flanking regions of RAP1 were independently cloned into the pSFS2A vector to generate pSFS2AdRAP1 (78). The DNA fragment carrying the regions flanking RAP1 and the SAT1-flipper cassette was excised from pSFS2AdRAP1 via ApaI/SacI digestion. The linear DNA was purified, transformed, and integrated into the C. albicans chromosome between the 5′ and 3′ flanking sequences of RAP1 via homologous recombination. The nourseothricin-resistant transformants were selected for validation by PCR (79). Then, the cells were grown in YPM to induce MAL2 promoter-regulated recombinase for SAT1-flipper excision from the RAP1 locus. The heterozygous RAP1 deletion mutants (rap1Δ/RAP1) were used for a second round of deletion cassette integration and excision to knock out the second allele of RAP1.

To construct the RAP1-reintegrated strains, the DNA fragment comprising the RAP1 promoter along with the full-length RAP1 coding sequence was amplified from the SC5314 genome using the primer pair Rap1-UR-F-ApaI and Rap1-DR-R-SacI. This fragment was cloned into pSFS2AdRAP1 upstream of the SAT1-flipper cassette to replace the original ApaI-SacI fragment, generating pRAP1R. The DNA fragment carrying the full-length RAP1 gene, the SAT1-flipper cassette, and the 5′ and 3′ flanking regions of RAP1 was excised from pRAP1R, purified, and transformed into the homozygous RAP1 deletion mutant (rap1Δ/Δ) strains. Nourseothricin selection and pop-out of the SAT1-flipper cassette were performed as described previously (79). The strains carrying the integration in the first allele of RAP1 were used to integrate RAP1 in the second allele. Finally, the successful strain construction was verified by PCR analysis of genomic DNA, using the primer pair RAP1-F and RAP1-R.

Cell sedimentation and flocculation assay.

Cells were grown overnight in YPD broth, and ~4.8 × 109 cells were transferred to test tubes and photographed immediately. The sedimentation assays were performed at room temperature, and cell sedimentation was recorded at different time points (80). To examine cell flocculation, 400 μL of cell suspension was transferred to each well of a 24-well flat-bottom plate with slow orbital shaking at room temperature for 30 min. Cells were then examined using bright-field microscopy.

Susceptibility to cell wall-perturbing agents.

Cell sensitivity to cell wall-perturbing agents was determined using a spot assay. The exponential-phase cells were collected by centrifugation and resuspended in sterile phosphate-buffered saline (PBS). Ten microliters of 10-fold serial dilutions was spotted onto SC agar plates with or without calcofluor white (180 μg/mL), Congo red (20 μg/mL), or tunicamycin (2.5 μg/mL, dissolved in dimethyl sulfoxide [DMSO]; Abcam, Cambridge, UK). Cell viability was recorded after incubation at 30°C for 3 days.

CSH assay.

The CSH assay was performed as previously described (81) with some modifications. Briefly, cells were collected by centrifugation and resuspended in 3 mL of PBS, and the optical density at 600 nm (OD600) was measured (A0). Then, 200 μL of xylene was mixed with the cell suspension and held at 30°C for 30 min to allow phase separation. The aqueous layer was transferred to a polystyrene tube, and its OD600 was measured (A1). The percentage of CSH was calculated as [(A0A1)/A0] × 100.

Measurement of cell wall carbohydrate content.

To assess the total carbohydrate content of the C. albicans cell wall, a phenol-sulfuric acid method was used as previously described (82) with some modifications. Cells were collected by centrifugation and resuspended in 1 mL Tris-EDTA (TE) buffer (pH 8) containing 0.3 g acid-washed glass beads. Cells were disrupted by vortexing for 30 s and placed on ice for 30 s, and this process was repeated six times. The cell wall pellets were collected by centrifugation and resuspended in 1 mL of TE buffer. Subsequently, 200 μL of the suspension was mixed with 1 mL of sulfuric acid (72% [vol/vol]; Fluka Chemie GmbH, Buchs, Switzerland) and 200 mL of phenol (5% [wt/vol]; J.T. Baker, Phillipsburg, NJ, USA). The mixture was incubated at room temperature for 10 min, followed by further incubation at 37°C for 30 min. Absorbance was measured with an iMark microplate absorbance reader (Bio-Rad, Hercules, CA, USA) at 490 nm, using different concentrations (0 to 200 mg/mL) of d-glucose as standards. To quantitate the content of mannan, glucan, and chitin, the cell wall pellets were obtained as described above, treated with sulfuric acid, boiled at 100°C, and neutralized with saturated Ba(OH)2 (82). The sample was analyzed using an HPAEC-PAD and a Dionex ICS-5000 system (Thermo Fisher Scientific, Waltham, MA, USA).

RNA extraction and RT real-time qPCR.

The exponential phase was used for total RNA extraction and reverse transcription for cDNA synthesis (79). For real-time qPCR, the StepOne Plus real-time PCR system (Applied Biosystems, Waltham, MA, USA) and the primers listed in Table S2 were used. In each 15-μL reaction mixture, 30 ng of cDNA, 300 nM (each) forward and reverse primer, and 7.5 μL of Power SYBR green PCR master mixture (Applied Biosystems) were included. The reactions were performed with 1 cycle at 95°C for 10 min, followed by 40 repeated cycles at 95°C for 15 s and 60°C for 1 min. The ACT1 transcripts were used as the internal control (83, 84). All experiments were performed in triplicate, with three independent experiments for each strain, and the average threshold cycle (CT) values were determined. Finally, the relative fold change in gene expression was calculated using the 2−ΔΔCT method (85).

Protein extraction and Western blotting.

Cells were collected and resuspended in a lysis buffer (50 mM HEPES [J.T. Baker], 5 mM EDTA [J.T. Baker], 1% Triton X-100 [United States Biological, Salem, MA, USA], 4 μM leupeptin, 0.2 mM phenylmethylsulfonyl fluoride [PMSF], 1 mM Na3VO4, 1 mM NaF [Fluka], 1 μM pepstatin A, and 1 μg/mL aprotinin). Cells were disrupted by vortexing with acid-washed glass beads, and total proteins were extracted as previously described (86). The total protein concentration was determined using a Bradford protein assay kit (Bio-Rad).

To detect activation of the Mkc1, Cek1, and Hog1 MAP kinases, proteins were resolved using 10% sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) as previously described (86). For Western blotting, anti-phospho-p44/42 MAPK antibody (catalog no. 4370; Cell Signaling Technology, Danvers, MA, USA) was used to detect phospho-Cek1 and phospho-Mkc1. Moreover, phospho-Hog1 and total Hog1 were detected using anti-phospho-p38 MAPK (catalog no. 9215; Cell Signaling Technology) and anti-Hog1 antibodies (catalog no. sc-9079; Santa Cruz Biotechnology, Santa Cruz, CA, USA), respectively; Act1 was detected using anti-β-actin antibody (catalog no. GTX09639; GeneTex, Hsinchu, Taiwan). Horseradish peroxidase (HRP)-conjugated IgG (catalog no. GTX213110-01; GeneTex) was used as the secondary antibody, and HRP was detected by the Western Lightning HRP chemiluminescent substrates (PerkinElmer, Waltham, MA, USA). Finally, the blot images were captured using an ImageQuant LAS 4000 biomolecular imager (GE Healthcare, Chicago, IL, USA).

Assessment of biofilm formation.

Cells were collected and adjusted to an OD600 of ~0.01 with 250 μL of SC broth in each well of a 24-well flat-bottom polystyrene microplate. For the assay of biofilm formation, cells were incubated at 37°C with 5% CO2 for 48 h (79). The wells were washed twice with sterile PBS to remove nonadherent cells. The extent of biofilm formation was determined as previously described (79), by measuring reduction of 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) at 490 nm as previously described (79).

To examine biofilm structure, 3 × 105 cells were placed on a Thermanox plastic coverslip (catalog no. 174950; Thermo Fisher Scientific) that was kept in each well of a 24-well microplate containing 1 mL of SC medium. After incubation at 37°C with 5% CO2 for 48 h, biofilm formed on the coverslip was washed, fixed, dehydrated, and dried as described before (79). The biofilms were examined and photographed using an S-4700 type II scanning electron microscope (SEM) (Hitachi).

Phagocytosis assay.

The murine macrophage cell line J774A.1 was grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with Gibco GlutaMAX, 10% Gibco heat-inactivated fetal bovine serum (FBS), and antibiotics-antimycotic (100 U/mL penicillin, 100 μg/mL streptomycin, and 0.25 μg/mL amphotericin B) at 37°C with 5% CO2. All the reagents to culture J774A.1 cells were purchased from Life Technologies (Carlsbad, CA, USA). Additionally, C. albicans cells were stained overnight at 4°C with 50 μg/mL fluorescein isothiocyanate (FITC; dissolved in PBS). For the phagocytosis assay, 2 × 105 J774A.1 cells were seeded on each well of a 6-well plate (AGC Techno Glass, Tokyo, Japan) containing a sterile coverslip with 2 mL of DMEM. The FITC-stained C. albicans cells were then added into each well containing J774A.1 cells at a multiplicity of infection (MOI) of 3 and coincubated at 37°C with 5% CO2 for 30 min, followed by washing and formaldehyde fixation. Moreover, nonphagocytosed cells were stained with 5 μg/mL calcofluor white at room temperature for 10 min. The percentage of C. albicans cells engulfed was assessed by analyzing at least 100 macrophages per well, using an Axio Imager A1 fluorescence microscope (Carl Zeiss, Jena, Germany).

Measurement of cytokine production.

C. albicans cells were collected, washed three times with PBS, and resuspended in DMEM without FBS. Additionally, 3 × 106 J774A.1 cells were seeded in each 60-mm culture dish (Corning Incorporated, Corning, NY, USA) containing 3 mL of DMEM. C. albicans cells were then added to each dish of J774A.1 cells (MOI of 3) and coincubated at 37°C with 5% CO2 for 24 h. The supernatant was collected and used to detect and quantify different secreted cytokines with cytokine ELISA kits (Invitrogen, Waltham, MA, USA). For the detection of IL-6, priming of macrophages with 0.5 ng/mL LPS (from Escherichia coli, Sigma-Aldrich) for 24 h was performed before C. albicans infection (87).

Virulence assay using G. mellonella infection model.

To study the role of Rap1 in C. albicans virulence, G. mellonella larvae (weighting 0.1 to 0.2 g) in the final instar stage were used (88, 89). Larvae were injected with C. albicans cells (5 × 105 cells suspended in PBS), incubated at 37°C, and monitored and recorded daily. Survival curves were plotted using the Kaplan-Meier method.

To assess fungal load, 6 × 105 cells of C. albicans (suspended in PBS) were injected into G. mellonella larvae, incubated at 37°C for 24 h. Twenty microliters of hemolymph was collected from individual larva of each infection group (containing 10 randomly chosen larvae), mixed with 20 mL of double-distilled water (ddH2O) to lyse the hemocyte, and plated onto YPD agar. The plates were incubated at 37°C for 3 to 4 days, and numbers of CFU were counted.

Statistical analysis.

The two-tailed Student t test was used to determine significant differences between samples. Statistical significance was indicated with a P value of <0.05.

ACKNOWLEDGMENTS

We thank Kei-Fung Lam for helping with the strain construction. We are also grateful to Joachim Morschhäuser (Universität Würzburg, Germany) for generously providing strains and plasmids.

This work was supported by grant number MOST109-2311-B-007-001-MY3 (to C.-Y.L.) from the Ministry of Science and Technology, Taiwan.

Footnotes

Supplemental material is available online only.

Supplemental file 1
Fig. S1 to S4 and Tables S1 and S2. Download spectrum.03285-22-s0001.pdf, PDF file, 1.8 MB (1.8MB, pdf)

Contributor Information

Chung-Yu Lan, Email: cylan@life.nthu.edu.tw.

Rebecca S. Shapiro, University of Guelph

REFERENCES

  • 1.Limon JJ, Skalski JH, Underhill DM. 2017. Commensal fungi in health and Disease. Cell Host Microbe 22:156–165. doi: 10.1016/j.chom.2017.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Mayer FL, Wilson D, Hube B. 2013. Candida albicans pathogenicity mechanisms. Virulence 4:119–128. doi: 10.4161/viru.22913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ. 2018. Invasive candidiasis. Nat Rev Dis Primers 4:18026. doi: 10.1038/nrdp.2018.26. [DOI] [PubMed] [Google Scholar]
  • 4.Garcia-Rubio R, de Oliveira HC, Rivera J, Trevijano-Contador N. 2019. The fungal cell wall: Candida, Cryptococcus, and Aspergillus species. Front Microbiol 10:2993. doi: 10.3389/fmicb.2019.02993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ruiz-Herrera J, Elorza MV, Valentin E, Sentandreu R. 2006. Molecular organization of the cell wall of Candida albicans and its relation to pathogenicity. FEMS Yeast Res 6:14–29. doi: 10.1111/j.1567-1364.2005.00017.x. [DOI] [PubMed] [Google Scholar]
  • 6.Ahmadipour S, Field RA, Miller GJ. 2021. Prospects for anti-Candida therapy through targeting the cell wall: a mini-review. Cell Surf 7:100063. doi: 10.1016/j.tcsw.2021.100063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Hasim S, Coleman JJ. 2019. Targeting the fungal cell wall: current therapies and implications for development of alternative antifungal agents. Future Med Chem 11:869–883. doi: 10.4155/fmc-2018-0465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Lenardon MD, Sood P, Dorfmueller HC, Brown AJP, Gow NAR. 2020. Scalar nanostructure of the Candida albicans cell wall; a molecular, cellular and ultrastructural analysis and interpretation. Cell Surf 6:100047. doi: 10.1016/j.tcsw.2020.100047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Gow NAR, Latge JP, Munro CA. 2017. The fungal cell wall: structure, biosynthesis, and function. Microbiol Spectr 5. doi: 10.1128/microbiolspec.FUNK-0035-2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Hall RA, Gow NA. 2013. Mannosylation in Candida albicans: role in cell wall function and immune recognition. Mol Microbiol 90:1147–1161. doi: 10.1111/mmi.12426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Gow NA, Hube B. 2012. Importance of the Candida albicans cell wall during commensalism and infection. Curr Opin Microbiol 15:406–412. doi: 10.1016/j.mib.2012.04.005. [DOI] [PubMed] [Google Scholar]
  • 12.Pellon A, Sadeghi Nasab SD, Moyes DL. 2020. New insights in Candida albicans innate immunity at the mucosa: toxins, epithelium, metabolism, and beyond. Front Cell Infect Microbiol 10:81. doi: 10.3389/fcimb.2020.00081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Alves R, Barata-Antunes C, Casal M, Brown AJP, Van Dijck P, Paiva S. 2020. Adapting to survive: how Candida overcomes host-imposed constraints during human colonization. PLoS Pathog 16:e1008478. doi: 10.1371/journal.ppat.1008478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Childers DS, Avelar GM, Bain JM, Larcombe DE, Pradhan A, Budge S, Heaney H, Brown AJP. 2020. Impact of the environment upon the Candida albicans cell wall and resultant effects upon immune surveillance. Curr Top Microbiol Immunol 425:297–330. doi: 10.1007/82_2019_182. [DOI] [PubMed] [Google Scholar]
  • 15.Cottier F, Hall RA. 2020. Face/off: the interchangeable side of Candida albicans. Front Cell Infect Microbiol 9:471. doi: 10.3389/fcimb.2019.00471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ibe C, Munro CA. 2021. Fungal cell wall proteins and signaling pathways form a cytoprotective network to combat stresses. J Fungi (Basel) 7:739. doi: 10.3390/jof7090739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Bruno VM, Kalachikov S, Subaran R, Nobile CJ, Kyratsous C, Mitchell AP. 2006. Control of the C. albicans cell wall damage response by transcriptional regulator Cas5. PLoS Pathog 2:e21. doi: 10.1371/journal.ppat.0020021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Heredia MY, Ikeh MAC, Gunasekaran D, Conrad KA, Filimonava S, Marotta DH, Nobile CJ, Rauceo JM. 2020. An expanded cell wall damage signaling network is comprised of the transcription factors Rlm1 and Sko1 in Candida albicans. PLoS Genet 16:e1008908. doi: 10.1371/journal.pgen.1008908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Mottola A, Ramírez-Zavala B, Hünniger K, Kurzai O, Morschhäuser J. 2021. The zinc cluster transcription factor Czf1 regulates cell wall architecture and integrity in Candida albicans. Mol Microbiol 116:483–497. doi: 10.1111/mmi.14727. [DOI] [PubMed] [Google Scholar]
  • 20.Kabir S, Sfeir A, de Lange T. 2010. Taking apart Rap1: an adaptor protein with telomeric and non-telomeric functions. Cell Cycle 9:4061–4067. doi: 10.4161/cc.9.20.13579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kyrion G, Liu K, Liu C, Lustig AJ. 1993. RAP1 and telomere structure regulate telomere position effects in Saccharomyces cerevisiae. Genes Dev 7:1146–1159. doi: 10.1101/gad.7.7a.1146. [DOI] [PubMed] [Google Scholar]
  • 22.Marcand S, Gilson E, Shore D. 1997. A protein-counting mechanism for telomere length regulation in yeast. Science 275:986–990. doi: 10.1126/science.275.5302.986. [DOI] [PubMed] [Google Scholar]
  • 23.Buchman AR, Kimmerly WJ, Rine J, Kornberg RD. 1988. Two DNA-binding factors recognize specific sequences at silencers, upstream activating sequences, autonomously replicating sequences, and telomeres in Saccharomyces cerevisiae. Mol Cell Biol 8:210–225. doi: 10.1128/mcb.8.1.210-225.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Shore D. 1994. RAP1: a protean regulator in yeast. Trends Genet 10:408–412. doi: 10.1016/0168-9525(94)90058-2. [DOI] [PubMed] [Google Scholar]
  • 25.Lu W, Zhang Y, Liu D, Songyang Z, Wan M. 2013. Telomeres-structure, function, and regulation. Exp Cell Res 319:133–141. doi: 10.1016/j.yexcr.2012.09.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Cai Y, Kandula V, Kosuru R, Ye X, Irwin MG, Xia Z. 2017. Decoding telomere protein Rap1: its telomeric and nontelomeric functions and potential implications in diabetic cardiomyopathy. Cell Cycle 16:1765–1773. doi: 10.1080/15384101.2017.1371886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Azad GK, Tomar RS. 2016. The multifunctional transcription factor Rap1: a regulator of yeast physiology. Front Biosci (Landmark Ed) 21:918–930. doi: 10.2741/4429. [DOI] [PubMed] [Google Scholar]
  • 28.Biswas K, Rieger KJ, Morschhäuser J. 2003. Functional analysis of CaRAP1, encoding the Repressor/activator protein 1 of Candida albicans. Gene 307:151–158. doi: 10.1016/s0378-1119(03)00456-6. [DOI] [PubMed] [Google Scholar]
  • 29.Uemura H, Watanabe-Yoshida M, Ishii N, Shinzato T, Haw R, Aoki Y. 2004. Isolation and characterization of Candida albicans homologue of RAP1, a repressor and activator protein gene in Saccharomyces cerevisiae. Yeast 21:1–10. doi: 10.1002/yea.1048. [DOI] [PubMed] [Google Scholar]
  • 30.Yu EY, Yen WF, Steinberg-Neifach O, Lue NF. 2010. Rap1 in Candida albicans: an unusual structural organization and a critical function in suppressing telomere recombination. Mol Cell Biol 30:1254–1268. doi: 10.1128/MCB.00986-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Nayyar A, Walker G, Wardrop F, Adya AK. 2017. Flocculation in industrial strains of Saccharomyces cerevisiae: role of cell wall polysaccharides and lectin-like receptors. J Inst Brew 123:211–218. doi: 10.1002/jib.421. [DOI] [Google Scholar]
  • 32.Stewart GG. 2018. Yeast flocculation—sedimentation and flotation. Fermentation 4:28. doi: 10.3390/fermentation4020028. [DOI] [Google Scholar]
  • 33.Hobden C, Teevan C, Jones L, O’Shea P. 1995. Hydrophobic properties of the cell surface of Candida albicans: a role in aggregation. Microbiology (Reading) 141:1875–1881. doi: 10.1099/13500872-141-8-1875. [DOI] [PubMed] [Google Scholar]
  • 34.Danchik C, Casadevall A. 2020. Role of cell surface hydrophobicity in the pathogenesis of medically-significant fungi. Front Cell Infect Microbiol 10:594973. doi: 10.3389/fcimb.2020.594973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Ene IV, Walker LA, Schiavone M, Lee KK, Martin-Yken H, Dague E, Gow NA, Munro CA, Brown AJ. 2015. Cell wall remodeling enzymes modulate fungal cell wall elasticity and osmotic stress resistance. mBio 6:e00986-15. doi: 10.1128/mBio.00986-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Mouyna I, Hartl L, Latge JP. 2013. β-1,3-Glucan modifying enzymes in Aspergillus fumigatus. Front Microbiol 4:81. doi: 10.3389/fmicb.2013.00081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.del Mar Gonzalez M, Diez-Orejas R, Molero G, Alvarez AM, Pla J, Nombela C, Sanchez-Perez M. 1997. Phenotypic characterization of a Candida albicans strain deficient in its major exoglucanase. Microbiology (Reading) 143:3023–3032. doi: 10.1099/00221287-143-9-3023. [DOI] [PubMed] [Google Scholar]
  • 38.Sarthy AV, McGonigal T, Coen M, Frost DJ, Meulbroek JA, Goldman RC. 1997. Phenotype in Candida albicans of a disruption of the BGL2 gene encoding a 1,3-β-glucosyltransferase. Microbiology (Reading) 143:367–376. doi: 10.1099/00221287-143-2-367. [DOI] [PubMed] [Google Scholar]
  • 39.Fonzi WA. 1999. PHR1 and PHR2 of Candida albicans encode putative glycosidases required for proper cross-linking of β-1,3- and β-1,6-glucans. J Bacteriol 181:7070–7079. doi: 10.1128/JB.181.22.7070-7079.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Brown AJ, Budge S, Kaloriti D, Tillmann A, Jacobsen MD, Yin Z, Ene IV, Bohovych I, Sandai D, Kastora S, Potrykus J, Ballou ER, Childers DS, Shahana S, Leach MD. 2014. Stress adaptation in a pathogenic fungus. J Exp Biol 217:144–155. doi: 10.1242/jeb.088930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.González-Rubio G, Fernández-Acero T, Martín H, Molina M. 2019. Mitogen-activated protein kinase phosphatases (MKPs) in fungal signaling: conservation, function, and regulation. Int J Mol Sci 20:1709. doi: 10.3390/ijms20071709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Martínez-Soto D, Ruiz-Herrera J. 2017. Functional analysis of the MAPK pathways in fungi. Rev Iberoam Micol 34:192–202. doi: 10.1016/j.riam.2017.02.006. [DOI] [PubMed] [Google Scholar]
  • 43.Smith SE, Csank C, Reyes G, Ghannoum MA, Berlin V. 2002. Candida albicans RHO1 is required for cell viability in vitro and in vivo. FEMS Yeast Res 2:103–111. doi: 10.1111/j.1567-1364.2002.tb00075.x. [DOI] [PubMed] [Google Scholar]
  • 44.Navarro-García F, Eisman B, Fiuza SM, Nombela C, Pla J. 2005. The MAP kinase Mkc1p is activated under different stress conditions in Candida albicans. Microbiology (Reading) 151:2737–2749. doi: 10.1099/mic.0.28038-0. [DOI] [PubMed] [Google Scholar]
  • 45.Levin DE. 2005. Cell wall integrity signaling in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 69:262–291. doi: 10.1128/MMBR.69.2.262-291.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Monge RA, Román E, Nombela C, Pla J. 2006. The MAP kinase signal transduction network in Candida albicans. Microbiology (Reading) 152:905–912. doi: 10.1099/mic.0.28616-0. [DOI] [PubMed] [Google Scholar]
  • 47.Eisman B, Alonso-Monge R, Román E, Arana D, Nombela C, Pla J. 2006. The Cek1 and Hog1 mitogen-activated protein kinases play complementary roles in cell wall biogenesis and chlamydospore formation in the fungal pathogen Candida albicans. Eukaryot Cell 5:347–358. doi: 10.1128/EC.5.2.347-358.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Herrero-de-Dios C, Alonso-Monge R, Pla J. 2014. The lack of upstream elements of the Cek1 and Hog1 mediated pathways leads to a synthetic lethal phenotype upon osmotic stress in Candida albicans. Fungal Genet Biol 69:31–42. doi: 10.1016/j.fgb.2014.05.010. [DOI] [PubMed] [Google Scholar]
  • 49.Nett JE, Sanchez H, Cain MT, Ross KM, Andes DR. 2011. Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation. Eukaryot Cell 10:1660–1669. doi: 10.1128/EC.05126-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Wang YC, Lan CY, Hsieh WP, Murillo LA, Agabian N, Chen BS. 2010. Global screening of potential Candida albicans biofilm-related transcription factors via network comparison. BMC Bioinformatics 11:53. doi: 10.1186/1471-2105-11-53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Bojang E, Ghuman H, Kumwenda P, Hall RA. 2021. Immune sensing of Candida albicans. J Fungi (Basel) 7:119. doi: 10.3390/jof7020119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Netea MG, Joosten LA, van der Meer JW, Kullberg BJ, van de Veerdonk FL. 2015. Immune defence against Candida fungal infections. Nat Rev Immunol 15:630–642. doi: 10.1038/nri3897. [DOI] [PubMed] [Google Scholar]
  • 53.Li B, Oestreich S, de Lange T. 2000. Identification of human Rap1: implications for telomere evolution. Cell 101:471–483. doi: 10.1016/s0092-8674(00)80858-2. [DOI] [PubMed] [Google Scholar]
  • 54.Konig P, Giraldo R, Chapman L, Rhodes D. 1996. The crystal structure of the DNA-binding domain of yeast RAP1 in complex with telomeric DNA. Cell 85:125–136. doi: 10.1016/s0092-8674(00)81088-0. [DOI] [PubMed] [Google Scholar]
  • 55.Martinez P, Blasco MA. 2017. Telomere-driven diseases and telomere-targeting therapies. J Cell Biol 216:875–887. doi: 10.1083/jcb.201610111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Boonekamp FJ, Dashko S, van den Broek M, Gehrmann T, Daran JM, Daran-Lapujade P. 2018. The genetic makeup and expression of the glycolytic and fermentative pathways are highly conserved within the Saccharomyces genus. Front Genet 9:504. doi: 10.3389/fgene.2018.00504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Shore D, Zencir S, Albert B. 2021. Transcriptional control of ribosome biogenesis in yeast: links to growth and stress signals. Biochem Soc Trans 49:1589–1599. doi: 10.1042/BST20201136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Müller T, Gilson E, Schmidt R, Giraldo R, Sogo J, Gross H, Gasser SM. 1994. Imaging the asymmetrical DNA bend induced by repressor activator protein 1 with scanning tunneling microscopy. J Struct Biol 113:1–12. doi: 10.1006/jsbi.1994.1027. [DOI] [PubMed] [Google Scholar]
  • 59.Mizuno T, Kishimoto T, Shinzato T, Haw R, Chambers A, Wood J, Sinclair D, Uemura H. 2004. Role of the N-terminal region of Rap1p in the transcriptional activation of glycolytic genes in Saccharomyces cerevisiae. Yeast 21:851–866. doi: 10.1002/yea.1123. [DOI] [PubMed] [Google Scholar]
  • 60.Bendjennat M, Weil PA. 2008. The transcriptional repressor activator protein Rap1p is a direct regulator of TATA-binding protein. J Biol Chem 283:8699–8710. doi: 10.1074/jbc.M709436200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Wotton D, Shore D. 1997. A novel Rap1p-interacting factor, Rif2p, cooperates with Rif1p to regulate telomere length in Saccharomyces cerevisiae. Genes Dev 11:748–760. doi: 10.1101/gad.11.6.748. [DOI] [PubMed] [Google Scholar]
  • 62.Levy DL, Blackburn EH. 2004. Counting of Rif1p and Rif2p on Saccharomyces cerevisiae telomeres regulates telomere length. Mol Cell Biol 24:10857–10867. doi: 10.1128/MCB.24.24.10857-10867.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Anbalagan S, Bonetti D, Lucchini G, Longhese MP. 2011. Rif1 supports the function of the CST complex in yeast telomere capping. PLoS Genet 7:e1002024. doi: 10.1371/journal.pgen.1002024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Palladino F, Laroche T, Gilson E, Axelrod A, Pillus L, Gasser SM. 1993. SIR3 and SIR4 proteins are required for the positioning and integrity of yeast telomeres. Cell 75:543–555. doi: 10.1016/0092-8674(93)90388-7. [DOI] [PubMed] [Google Scholar]
  • 65.Teixeira MT, Arneric M, Sperisen P, Lingner J. 2004. Telomere length homeostasis is achieved via a switch between telomerase-extendible and -nonextendible states. Cell 117:323–335. doi: 10.1016/S0092-8674(04)00334-4. [DOI] [PubMed] [Google Scholar]
  • 66.Jain D, Cooper JP. 2010. Telomeric strategies: means to an end. Annu Rev Genet 44:243–269. doi: 10.1146/annurev-genet-102108-134841. [DOI] [PubMed] [Google Scholar]
  • 67.Azad GK, Singh V, Baranwal S, Thakare MJ, Tomar RS. 2015. The transcription factor Rap1p is required for tolerance to cell-wall perturbing agents and for cell-wall maintenance in Saccharomyces cerevisiae. FEBS Lett 589:59–67. doi: 10.1016/j.febslet.2014.11.024. [DOI] [PubMed] [Google Scholar]
  • 68.Hazen KC. 1989. Participation of yeast cell surface hydrophobicity in adherence of Candida albicans to human epithelial cells. Infect Immun 57:1894–1900. doi: 10.1128/iai.57.7.1894-1900.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Nobile CJ, Fox EP, Nett JE, Sorrells TR, Mitrovich QM, Hernday AD, Tuch BB, Andes DR, Johnson AD. 2012. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell 148:126–138. doi: 10.1016/j.cell.2011.10.048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Nobile CJ, Johnson AD. 2015. Candida albicans biofilms and human disease. Annu Rev Microbiol 69:71–92. doi: 10.1146/annurev-micro-091014-104330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Tsui C, Kong EF, Jabra-Rizk MA. 2016. Pathogenesis of Candida albicans biofilm. Pathog Dis 74:ftw018. doi: 10.1093/femspd/ftw018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Briard B, Fontaine T, Kanneganti TD, Gow NAR, Papon N. 2021. Fungal cell wall components modulate our immune system. Cell Surf 7:100067. doi: 10.1016/j.tcsw.2021.100067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Moretti P, Freeman K, Coodly L, Shore D. 1994. Evidence that a complex of SIR proteins interacts with the silencer and telomere-binding protein RAP1. Genes Dev 8:2257–2269. doi: 10.1101/gad.8.19.2257. [DOI] [PubMed] [Google Scholar]
  • 74.De Las Peñas A, Pan SJ, Castaño I, Alder J, Cregg R, Cormack BP. 2003. Virulence-related surface glycoproteins in the yeast pathogen Candida glabrata are encoded in subtelomeric clusters and subject to RAP1- and SIR-dependent transcriptional silencing. Genes Dev 17:2245–2258. doi: 10.1101/gad.1121003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Gurevich R, Smolikov S, Maddar H, Krauskopf A. 2003. Mutant telomeres inhibit transcriptional silencing at native telomeres of the yeast Kluyveromyces lactis. Mol Genet Genomics 268:729–738. doi: 10.1007/s00438-002-0788-9. [DOI] [PubMed] [Google Scholar]
  • 76.Lieb JD, Liu X, Botstein D, Brown PO. 2001. Promoter-specific binding of Rap1 revealed by genome-wide maps of protein-DNA association. Nat Genet 28:327–334. doi: 10.1038/ng569. [DOI] [PubMed] [Google Scholar]
  • 77.Nobile CJ, Andes DR, Nett JE, Smith FJ, Yue F, Phan QT, Edwards JE, Filler SG, Mitchell AP. 2006. Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog 2:e63. doi: 10.1371/journal.ppat.0020063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Reuss O, Vik A, Kolter R, Morschhäuser J. 2004. The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene 341:119–127. doi: 10.1016/j.gene.2004.06.021. [DOI] [PubMed] [Google Scholar]
  • 79.Chen HF, Lan CY. 2015. Role of SFP1 in the regulation of Candida albicans biofilm formation. PLoS One 10:e0129903. doi: 10.1371/journal.pone.0129903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Hsu PC, Chao CC, Yang CY, Ye YL, Liu FC, Chuang YJ, Lan CY. 2013. Diverse Hap43-independent functions of the Candida albicans CCAAT-binding complex. Eukaryot Cell 12:804–815. doi: 10.1128/EC.00014-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.de Souza RD, Mores AU, Cavalca L, Rosa RT, Samaranayake LP, Rosa EA. 2009. Cell surface hydrophobicity of Candida albicans isolated from elder patients undergoing denture-related candidosis. Gerodontology 26:157–161. doi: 10.1111/j.1741-2358.2008.00229.x. [DOI] [PubMed] [Google Scholar]
  • 82.François JM. 2006. A simple method for quantitative determination of polysaccharides in fungal cell walls. Nat Protoc 1:2995–3000. doi: 10.1038/nprot.2006.457. [DOI] [PubMed] [Google Scholar]
  • 83.Chau AS, Mendrick CA, Sabatelli FJ, Loebenberg D, McNicholas PM. 2004. Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to azoles. Antimicrob Agents Chemother 48:2124–2131. doi: 10.1128/AAC.48.6.2124-2131.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Frade JP, Warnock DW, Arthington-Skaggs BA. 2004. Rapid quantification of drug resistance gene expression in Candida albicans by reverse transcriptase LightCycler PCR and fluorescent probe hybridization. J Clin Microbiol 42:2085–2093. doi: 10.1128/JCM.42.5.2085-2093.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 25:402–408. doi: 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]
  • 86.Hsu CM, Liao YL, Chang CK, Lan CY. 2021. Candida albicans Sfp1 is involved in the cell wall and endoplasmic reticulum stress responses induced by human antimicrobial peptide LL-37. Int J Mol Sci 22:10633. doi: 10.3390/ijms221910633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Bartosh TJ, Ylostalo JH. 2014. Macrophage inflammatory assay. Bio Protoc 4:e1180. doi: 10.21769/bioprotoc.1180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Fuchs BB, O’Brien E, Khoury JB, Mylonakis E. 2010. Methods for using Galleria mellonella as a model host to study fungal pathogenesis. Virulence 1:475–482. doi: 10.4161/viru.1.6.12985. [DOI] [PubMed] [Google Scholar]
  • 89.Yeh YC, Wang HY, Lan CY. 2020. Candida albicans Aro1 affects cell wall integrity, biofilm formation and virulence. J Microbiol Immunol Infect 53:115–124. doi: 10.1016/j.jmii.2018.04.002. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental file 1

Fig. S1 to S4 and Tables S1 and S2. Download spectrum.03285-22-s0001.pdf, PDF file, 1.8 MB (1.8MB, pdf)


Articles from Microbiology Spectrum are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES